Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.447 SEK | -4.89% | -2.72% | -14.53% |
04-16 | Mendus AB Announces Board Changes | CI |
03-27 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MENDUS AB | Other Biotechnology & Medical Research | -4.89% | -2.72% | -14.53% | -68.52% | -94.32% | 43.75M |
Technical Rankings Surperformance
- Stock Market
- Equities
- IMMU Stock
- Charts Mendus AB
- Comparison Chart